BRCA1 and breast carcinoma: Nevertheless in order to further substantiate that the BRCA1-mutation DNAme signature identifies sporadic cancers, we performed a nested case–control study within the UKCTOCS cohort (a 202,638 postmenopausal women cohort, who based on their family history were not at an increased risk of ovarian or breast cancer - see Additional files 3 and 4).